Amylyx Pharmaceuticals (AMLX) Enterprise Value Growth (3y) (2024 - 2026)

Amylyx Pharmaceuticals (AMLX) Enterprise Value Growth (3y) (2024 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.76 Bn	42.80 Bn	-
2	Teva Pharmaceutical Industries	43.05 Bn	39.39 Bn	2.15 Bn
3	Zoetis	31.51 Bn	29.84 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.70 Bn	22.90 Bn	5.10 Bn
5	United Therapeutics	22.27 Bn	19.61 Bn	683.80 Mn
6	Viatris	18.83 Bn	17.95 Bn	1.46 Bn
7	Neurocrine Biosciences	15.65 Bn	15.26 Bn	935.80 Mn
8	Elanco Animal Health	12.06 Bn	11.53 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.12 Bn	9.95 Bn	-
10	Amylyx Pharmaceuticals	4.34 Bn	4.34 Bn	-

Download Data